Is (1,3)-β-D-glucan useless to guide antifungal therapy in ICU?

Rouzé, AnahitaEstella, ÁngelTimsit, Jean-François2023-05-032023-05-032022-06-30http://hdl.handle.net/10668/19586enAntifungal AgentsGlucansHumansIntensive Care UnitsProteoglycansbeta-GlucansIs (1,3)-β-D-glucan useless to guide antifungal therapy in ICU?research article35771251open access10.1007/s00134-022-06766-21432-1238https://link.springer.com/content/pdf/10.1007/s00134-022-06766-2.pdf